Merck Stock Target Price and Analyst Consensus

MRK Stock  USD 103.46  0.98  0.96%   
The prevalent analyst and expert consensus on Merck is Buy with 16 strong buy estimates. The prevailing projected target price is 126.2 with 20 professional opinions. Some of the most common ways Merck Company analysts use to provide public buy-or-sell recommendation are financial statements evaluation and conference calls analysis. They also talk to Merck executives, vendors, and customers. Merck buy-or-sell recommendation and consensus module provides average expert sentiment on the projected Merck Company target price to derive its highest and lowest estimates based on target price volatility of 5.872. Check out Macroaxis Advice on Merck to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast
115
Highest Forecast
135
Target Price
126.2
The value of Gross Profit is estimated to slide to about 39 B. The value of Profit Margin is estimated to slide to 0.23. At this time, Merck's Investments Current are quite stable as compared to the past year. . Investments Non Current is expected to rise to about 1 B this year, although the value of Accumulated Other Comprehensive Income will most likely fall to (5.1 B).
  
It's important to approach Merck's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Merck Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Merck target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Merck's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
Number of Opinions19
Lowered Outlook1
Raized Outlook1
Buy
Most Merck analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Merck stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Merck Company, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Merck Target Price Projection

Merck's current and average target prices are 103.46 and 126.20, respectively. The current price of Merck is the price at which Merck Company is currently trading. On the other hand, Merck's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Merck Market Quote on 4th of December 2023

Low Price102.68Odds
High Price103.68Odds

103.46

Target Price

Analyst Consensus On Merck Target Price

Low Estimate115.0Odds
High Estimate135.0Odds
Number of Analysts20
Standard Deviation5.872

126.2

Historical Lowest Forecast  115.0 Target Price  126.2 Highest Forecast  135.0
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Merck Company and the information provided on this page.

Merck Analyst Ratings

Merck's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Merck stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Merck's financials, market performance, and future outlook by experienced professionals. Merck's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Merck price targets

Merck's stock target price is an estimate of its future price, usually made by analysts. Using Merck's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Merck's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Merck's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Merck Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Merck is a key component of Merck valuation and have some predictive power on the future returns of a Merck.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Merck's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Merck in the context of predictive analytics.
Hype
Prediction
LowEstimatedHigh
102.48103.40104.32
Details
Intrinsic
Valuation
LowRealHigh
93.11115.02115.94
Details
Naive
Forecast
LowNextHigh
103.54104.46105.38
Details
Earnings
Estimates (8)
LowProjected EPSHigh
-0.120.151.88
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Merck. Your research has to be compared to or analyzed against Merck's peers to derive any actionable benefits. When done correctly, Merck's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Merck Company.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Impulse Idea
Impulse
Invested over 100 shares
Manufacturing Idea
Manufacturing
Invested over 40 shares
Social Domain Idea
Social Domain
Invested over 20 shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Banking Idea
Banking
Invested over 30 shares
ESG Investing Idea
ESG Investing
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested over 70 shares
FinTech Idea
FinTech
Invested over 60 shares
Business Services Idea
Business Services
Invested over 100 shares
When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:
Check out Macroaxis Advice on Merck to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for Merck Stock analysis

When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Bonds Directory
Find actively traded corporate debentures issued by US companies
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
The data published in Merck's official financial statements usually reflect Merck's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Merck Company. For example, before you start analyzing numbers published by Merck accountants, it's critical to develop an understanding of what Merck's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Merck's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Merck's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Merck's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Merck Company. Please utilize our Beneish M Score to check the likelihood of Merck's management manipulating its earnings.